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Introduction 
The management of periodontal defects has been an ongoing challenge in clinical 
periodontics.  This is mainly due to the fact that the tissues which comprise the periodontium, 
the periodontal ligament, cementum and alveolar bone, represent three unique tissues in their 
own right.  Thus, reconstruction of the periodontium is not just a simple matter of 
regenerating just one tissue but involves at least three quite diverse and unique tissues.  
Resective surgical therapy with or without osseous recontouring was considered the 
norm during the 1950’s and into the 1960’s in the belief that attainment of shallow pocket 
depths was a worthwhile goal.  More recently attention has been focussed more on 
regenerative and reconstructive therapies rather than resective therapies.  Currently clinical 
and scientific research is focussing on a number of approaches for periodontal regeneration.   
One approach requires the introduction of a “filler” material into a periodontal defect 
in the hope of inducing bone regeneration. Various types of bone grafts have been 
investigated to determine their ability to stimulate new bone formation.  Of these, the 
following have been studied in detail: (1) Alloplastic materials which are generally synthetic 
filler materials; (2) Autografts which are grafted tissue from one site to another in the same 
individual; (3) Allografts of tissue between individuals of the same species but with different 
genetic composition; (4) Xenografts which consist of grafted materials between different 
species.  Although utilization of such grafting materials for periodontal defects may result in 
some gain in clinical attachment levels and radiographic evidence of bone fill, careful 
histologic assessment usually reveals that these materials have little osteoinductive capacity 
and generally become encased in a dense fibrous connective tissue (19). 
In another approach to induce periodontal regeneration, polypeptide growth factors 
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have been locally applied to the root surface in order to facilitate the cascade of wound 
healing events that lead to new cementum and connective tissue formation.  Among the 
myriad growth factors currently characterized and available, platelet-derived growth factor 
(PDGF) and insulin-like growth factor-1 (IGF-I), have been noted to enhance regeneration of 
periodontal defects in beagle dogs and monkeys (42, 61).  Another promising group of 
polypeptide growth factors is the bone morphogenetic proteins (BMP), which offer good 
potential for stimulating bone and cementum regeneration (59).  An extension of growth 
factor application to root surfaces is the application of cell free matrix constructs to the root 
surface to aid cell repopulation and enhance regeneration.  Enamel matrix proteins, are such 
an example and there is some evidence that these proteins can assist in the regeneration of 
periodontal tissues (24, 80).  It is postulated that the enamel matrix derivative acts as a matrix 
enhancement factor, creating a positive environment for cell proliferation, differentiation and 
matrix synthesis (43, 23).   
Yet another approach, known as guided tissue regeneration (GTR), has been 
developed to achieve periodontal regeneration.  This utilizes barrier membranes to guide and 
instruct the specialized cellular components of the periodontium to participate in the 
regenerative process. The GTR concept was founded on sound scientific research, and based 
on the premise that the periodontal ligament contained all of the progenitor cells required for 
the formation of bone, cementum and periodontal ligament (21, 35, 52).  Through 
repopulation of the wound site by the progenitor cells periodontal regeneration could be 
induced.  Although this procedure became widely accepted as a clinical procedure (35, 48), 
recent clinical evaluation has indicated that the clinical improvements obtained by this 
procedure are small and highly variable (10, 56, 78). 
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It now seems likely that a combination of several techniques may offer the most likely 
chance of a beneficial outcome.  Through a combination of transplanted biomaterials 
containing appropriately selected and primed cells, together with an appropriate mix of 
regulatory factors and extracellular matrix components to allow growth and specialization of 
the cells, new therapies are emerging of significant clinical potential (4). 
Tissue engineering is defined as the reconstruction of living tissues to be used for the 
replacement of damaged or lost tissue / organs of living organisms and is founded on 
principles of cell biology, developmental biology and biomaterials science (49, 71, 60).  This 
developing area of applied biomedical research is attracting considerable attention from both 
the private and government sectors because of its considerable economic and therapeutic 
potential (44, 54).  A clear distinction should be made between tissue engineering, which is 
the implantation of in vitro seeded cells and matrices, versus guided tissue regeneration which 
involves the approach of using acellular matrices that are repopulated by the host after 
implantation.   
  Successful tissue engineering requires an interplay between three components 
(Figure 1) (i) the implanted and cultured cells that will create the new tissue; (ii) a biomaterial 
to act as a scaffold or matrix to hold the cells and, (iii) biological signalling molecules that 
instruct the cells to form the desired tissue type. This review will focus mainly on the use of 
scaffold materials used to transplant cells as a means of either delivering cells or proteins to a 
defect site. 
 
Periodontal Tissue Engineering  
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The principal requirements for tissue engineering are the incorporation of appropriate 
numbers of responsive progenitor cells and the presence of bioactive levels of regulatory 
signals within an appropriate extracellular matrix or carrier construct.  Recent advances in the 
isolation of mesenchymal stem cells, growth factor biology, and biodegradable polymer 
constructs have set the stage for successful tissue engineering of many tissues of which the 
periodontium could be considered a prime candidate for such procedures.  Preliminary studies 
have indicated that periodontal ligament and bone cells can be transplanted into periodontal 
sites with no adverse immunologic or inflammatory consequences (38, 46, 75, 82).   
 In order for successful periodontal regeneration to occur, it will be necessary to 
utilize and recruit progenitor cells which can differentiate into specialized cells with a 
regenerative capacity followed by proliferation of these cells, and synthesis of the specialized 
connective tissues which they are attempting to repair. Clearly, a tissue engineering approach 
for periodontal regeneration will need to utilize the regenerative capacity of cells residing 
within the periodontium and would involve the isolation of such cells and their subsequent 
within a three-dimensional framework with implantation into the defect.  The use of a 
prefabricated three dimensional scaffold with the appropriate cells or instructive messages 
(eg, growth factors and matrix attachment factors) incorporated into it may overcome many of 
the limitations associated with current regenerative technologies.   With the current success 
reported for other systems, a tissue engineering approach to regenerate periodontal defects 
seems reasonable (4). 
 Despite the above positive outlook, there are still many issues that need to be dealt 
with before periodontal tissue engineering becomes commonplace.  There are two main 
criteria for successful tissue engineering (11, 64, 5).  Firstly, there are the engineering 
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principals which relate to biomechanical properties of the scaffold, architectural geometry and 
space maintaining properties.  The second criterion relates to the biological functions of the 
engineered construct including cell recruitment, cell proliferation, cell survival in culture and 
at the site of implantation, neovascularization and delivery of morphogenetic-, regulatory- and 
growth-factors necessary for successful tissue regeneration.  In this review we will 
specifically focus on design requirements of scaffolds for cell delivery and then discuss some 
of the materials and methods which have been used in recent years.  
  
Design Requirements for Cell Seeding Scaffolds 
Space maintenance within the defect site and Barrier or exclusionary functions.   
The important understanding that bone will grow into an adjacent tissue space 
providing that space can be maintained and soft tissue ingrowth prevented is not new (7, 30).  
These early observations, which led to the principles of guided tissue regeneration, provide a 
fundamental concept when considering tissue engineering and placement of bioengineered 
matrices for regeneration.  Thus, any engineered material should be of sufficient form and 
strength to allow placement into a defect that prevents subsequent collapse of the overlying 
tissues into the defect site.  Indeed, the material should act in a manner consistent with the 
established principles of guided tissue regeneration (62).  These principles dictate that 
sufficient wound space and a suitable environment for regeneration will act synergistically to 
permit the uninhibited cascade of molecular and cellular events required for the regenerative 
process. 
The necessary design features needed to obtain adequate space maintenance will 
include ease of handling and shaping, sufficient rigidity to withstand soft tissue collapse into 
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the defect and an internal structure compatible with cell attachment and colonization, as well 
as permitting the in growth of tissues compatible with those to be regenerated (11, 62, 79).   
 
Biocompatibility and design features. 
An ideal material for tissue engineering scaffolds will require it to be either 
biocompatible with the tissues to be regenerated or biodegradable allowing for gradual 
replacement by regenerated tissue  (36).  Since both cell attachment and incorporation in vitro 
as well as subsequent tissue maturation during in situ regeneration are crucial features of 
tissue engineering, the amount of porosity and the pore size of the supporting three 
dimensional structure are also important features which need to be taken into consideration 
when designing tissue engineering scaffolds (79, 9).  Finally, biosafety of the tissue 
engineered constructs needs to be taken into consideration.  Although no guidelines have yet 
been established for assessment of the safety and efficacy of cell-based and tissue-based 
tissue-engineered products, clearly these materials should be free from transmittable disease 
and be immunologically inert while not inducing an overexuberant inflammatory response 
(53).  Indeed, the ability of the host to accept the implanted materials depends not only on the 
material used but also the host reaction and the systemic health of the recipient (58). 
 
Incorporation of cells with appropriate phenotype for ongoing periodontal regeneration.   
Bioengineered skin substitutes with incorporated cells and extracellular matrix have 
been available for some time (55).  These artificial constructs can provide almost unlimited 
quantities of tissue for wound management and illustrate the potential of such an approach.  
With increasing knowledge of what constitutes cells with a “periodontal regenerative 
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phenotype” (32) together with the identification of adult mesenchymal stem cells within the 
periodontal ligament (63) it should be possible to culture and subsequently incorporate these 
cells into a suitable biodegradable scaffold for immediate introduction into a periodontal 
defect.  
More recently, viral vectors transformed into mesenchymal cells have been used as a 
novel means of introducing specific molecules to wound sites with the intention of 
stimulating tissue regeneration (51).  Interestingly this technology has already been 
translocated into periodontal regeneration.  Using a viral vector delivery system, genetically 
altered cells which express certain growth factors necessary for periodontal regeneration 
(specifically PDGF) have been introduced into periodontal defects and appear to be able to 
significantly enhance the regenerative response in experimental animal models (34, 1).  Such 
procedures introduce the problem of biosafety with regards to genetic manipulation and 
control of the process, which will have to be dealt with prior to clinical acceptance.     
For periodontal tissue engineering, potential sources of cells are from cementum (85), 
periodontal ligament (63) and bone (81, 82).  Whether the so-called progenitor cells which 
reside in these tissues can be isolated and propagated in culture for future seeding remains to 
be established (86).   
  
Incorporation and bioavailability of instructive messages.  
Growth and differentiation factors are essential ingredients for tissue regeneration.  
Hence the synthetic scaffold used for tissue engineering should not only be bioresorbable but 
also constructed from a material with a suitable affinity for the adsorption of appropriate 
growth/differentiation factors as well as integrins, cell receptors and other instructive 
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molecules normally found in regenerating tissues (65, 8, 28).  Notwithstanding this important 
requisite, choosing the “correct” agent or agents is a formidable task.  The plethora of 
bioactive molecules involved in tissue regeneration will make rational selection of specific 
agents very difficult.  However, as our understanding of the precise signalling molecules 
required for optimal growth, differentiation and gene expression become available, it is 
anticipated that these agents may be incorporated into engineered matrices for regenerative 
purposes based on sound biologic principles.   
Although biological molecules can relatively easily be conjugated to an artificial 
tissue engineered scaffold, issues relating to suitable release and delivery kinetics will become 
the major focus of interest.  Obstacles yet to be overcome in this regard will be controlling the 
concentration, local duration and spatial distribution of these bound factors.  Indeed the 
control and containment of the agent is paramount for its effectiveness and safety (8).   
Recently, bioengineers have devised novel methods to create a self-assembled 
molecular structure that responds to ultrasonic energy by releasing a burst of entrapped drug 
(37).  Moreover, the self-assembling structure is a barrier to drug release in the absence of 
ultrasonic energy, reducing the problem of overt leakage from an indwelling device.  The 
prototype for this has shown favourable release rates for insulin, as well as for an antibiotic 
compound, ciprofloxacin, when triggered by ultrasonic energy.  In these tests, essentially no 
drug leakage occurred in the absence of an appropriate energy signature.  This work also 
suggests that self-assembling structures could be devised to serve as a barrier while 
simultaneously serving as an ultrasonic responsive drug release device to promote tissue 
regeneration strategies.  Such molecularly triggered devices might also permit the placement 
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of appropriate therapeutic regimen that would be released only by the practitioner when 
required to match a clinical scenario. 
 
Regulating Cell Activity through Scaffold Design 
It has been recognized for many years that the microenvironment in which a cell 
resides dictates many functions and phenotypes (27).  Thus it seems logical that the 
construction and design of a cell seeding scaffold must take into account microenvironment 
design features to induce the appropriate gene expression in cells forming new tissues.  The 
control of gene expression by cells within a scaffold can be regulated via interactions with the 
adhesion surface, with other cells in the vicinity or, as described above, incorporated growth 
and differentiation factors in the scaffold.  Accordingly cell seeding scaffolds must provide 
the correct combination of these factors according to the tissues to be regenerated if one is to 
achieve successful gene expression and tissue regeneration.  To date little work has been done 
in this complex area although early studies have begun to utilize specific cell attachment 
peptide sequences (“RGD” sequence for integrins), pore size, and surface texture in attempts 
to improve tissue integration and regeneration. 
When considering scaffold design many tissues depend upon mechanical stimuli in 
order regulate gene expression and thus tissue composition.  The most obvious example of 
this is bone and tendon although it is likely that the periodontal ligament should also be 
considered in this context.  In order to engineer such functional tissues the correct mechanical 
stimuli will need to be conveyed to the developing tissues within the cell/scaffold construct.  
To date, because of the complexities of such systems very few studies have addressed these 
issues (41). 
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Types of Cell Delivery Devices and Scaffolds 
A common approach to tissue engineering is to use an exogenous three-dimensional 
extracellular matrix to engineer new tissues using isolated cells.  The exogenous matrix 
constructs are designed to encourage cells to come into contact with it in a suitable three 
dimensional environment and provide structural support for the newly forming tissues.  More 
recently a variant of this approach has been to isolate cells from biopsy specimens and expand 
them in vitro prior to seeding onto a suitable three dimensional matrix.  In doing so the cells 
are allowed to either develop into a new tissue in vitro or immediately transplanted to a 
particular site to create new functional tissue which is integrated within the recipient site.   
 Most cell seeding scaffolds are fabricated from two classes of biomaterials derived 
from either synthetic or natural products.  In addition they may be constructed from either a 
resorbable or nonresorbable materials (Table 1). Natural products such as collagen are known 
to have specific desirable biologic properties such as permitting cell interactions but have the 
disadvantages of being derived from animal or human tissue leading to questions over 
availability, safety and batch-to-batch variations.  In contrast, synthetic materials can be 
produced on a large scale to specific design criteria from generally inert, biocompatible and 
biodegradable materials.  Not surprisingly, there has been a plethora of materials developed 
and studied over the years, each claiming specific and unique advantages over “competitor” 
products.  Therefore the following discussion is restricted to examples of cell carrier and 
delivery devices currently under investigation and of relevance to periodontal regeneration. 
 
Non-Resorbable Materials 
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Expanded poly tetrafluoroethylene (ePTFE, Goretex™)  
Membranes made from ePTFE have traditionally been used as guided tissue barrier 
membranes.  However, it is possible that these membranes could also be used to nurture 
specific cells that are expanded ex vivo and then delivered to a defect site.  In the same context 
almost any GTR membrane could be utilized in such a manner utilizing either non-resorbable 
or resorbable materials (Figure 2). 
 
Porous Ceramic Scaffolds 
Several porous ceramic scaffolds have been examined for their utilization as cell 
delivery materials.  In general, many of these materials have been developed and investigated 
with regard to bone tissue engineering (69).  For these purposes the ideal scaffold should be a 
porous material with good biocompatibility and possess osseointegrative capabilities, high 
mechanical strength and biodegradability.  Some ceramic materials have the former two 
properties but to date no porous scaffolds satisfy both of the latter two properties.   
Hydroxyapatite is an example of a material with good mechanical properties but due 
to its porosity this materials has poor strength.  Another problem with porous hydroxyapatite 
is the lack of interconnectivity of the pores making neovascularization of any implant almost 
impossible.  Many studies have shown that hydroxyapatite scaffolds cultured with bone cells 
have good osteogenic potential (16). 
Biodegradable porous ceramic materials have also been developed and investigated.  
Of these, the most popular material possessing high biocompatibility and biodegradability is 
beta-tricalcium phosphate (TCP). When implanted alone at extraskeletal sites, TCP undergoes 
rapid degradation with little bone formation.  Due to this rapid degradation of TCP and its 
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associated poor mechanical properties, research has focussed on mixed calcium phosphates, 
such as mixtures of beta-TCP and hydroxyapatite or beta-TCP and polymers.  These hybrid 
materials appear to be good vehicles for cell delivery with studies showing good tissue 
formation associated with the implanted cells (22, 16). 
 
Titanium Mesh 
Another nonresorbable scaffold that has received considerable attention in recent years 
is titanium mesh (33).  This material has good mechanical properties with regards to stiffness 
and elasticity and is relatively easy to handle during surgical placement.  The lack of 
bioresorbabilty of this material can be advantageous for the management of large osseous 
defects whereby the mesh retains sufficient rigidity to avoid collapse which would be 
expected of teflon membranes or biodegradable scaffolds.  Various studies have indicated that 
this material is suitable to support the growth and osteogenic expression of bone marrow cells 
(74, 72, 77).  Through various surface treatments, including addition of fibronectin, collagen 
or calcium phosphate, the rate and amount of bone formation by implanted cells into titanium 
mesh scaffolds can be regulated (76, 73). 
 
Resorbable materials 
Resorbable materials offer the significant advantage they do not need to be retrieved at 
a later date from the site of implantation.  These materials include materials such as polyesters 
of naturally occurring alpha-hydroxy acids, amino-acid based polymers, alginate and natural 
materials such as collagen and reconstituted extracellular matrix proteins.   
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Alpha Hydroxy Acids 
The alpha-hydroxy acid polymers include polyglycolic acid (PGA), poly (L-lactic 
acid) PLLA and copolymers of poly (lactic-co-glycolic acid) PLGA).  These materials have 
been used extensively for cell seeding in tissue engineering (66, 83).  Their ester bonds are 
quite susceptible to hydrolysis and thus degrade by nonenzymatic means.  Accordingly these 
natural breakdown products are removed from the site of implantation by normal tissue 
respiratory routes and do not generally elicit a foreign body response resulting in massive 
macrophage infiltration and chronic inflammation.  Through specific chemical manipulation 
these materials can be fabricated to degrade over long or short periods of time depending on 
the need.  These materials can also be easily manufactured into preformed sizes and shapes as 
dictated by the site of the defect and its anatomy. 
However, these materials are hydrophobic and are processed under quite stringent 
(biologically adverse) conditions which usually makes factor incorporation and attachment or 
entrapment of cells difficult.  Recently a biodegradable copolymer of L-lactic acid, D-lactic 
acid, glycolic acid and trimethylene carbonate have been developed (Inion, Ltd, Finland).  
Although originally developed for use in dentistry as exclusionary barrier membranes, these 
biodegradable membranes offer good potential as cell delivery devices with the advantage 
that they seem to allow cell attachment more readily than other inert materials such as ePTFE 
(Figure 2). 
 
Alginate 
An alternative to alginate gels as a carrier of cells is the incorporation of cells into 
beads of alginate (Figure 3) (70).  The technique is based on entrapment of individual cells 
 16
and tissues into an alginate droplet that is transformed into a rigid bead by gelation in a 
divalent cation rich solution.  The cells are surrounded by a nondegradable, selectively 
permeable barrier which isolates the transplanted cells from host tissue and larger molecular 
weight solutes.  Such implants are considered immunoprotective as they prevent immune cells 
and soluble complexes from killing the transplanted cells and this property negates the need 
for use of immunosuppressants (68).  While these systems may be used to deliver cells to a 
specific site, because of the entrapment of the cells within an encapsulated environment, there 
is little opportunity for direct and immediate cell/matrix interaction at the site of implantation.  
Moreover, as a result of the semipermeable nature of the beads, the soluble factors made by 
the entrapped cells can be released at the implantation site to guide regenerated tissues.  In 
recent years, these devices have been more appropriately developed as drug delivery devices 
than cell delivery devices for tissue engineering (68).   
 
Amino Acid Polymers 
Amino acid based polymers have also been used as scaffolds for cell seeding.  These 
scaffolds can be synthesized using fermentation and gene transfer technology to produce 
molecules which resemble natural amino acid containing matrix molecules such as collagens, 
and elastin (29).  While these materials have the advantage of being able to interact well with 
cells, issues of biosafety (immunogenicity), large scale production and purification from 
unwanted contaminants remain a problem (36) 
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Scaffolds Derived from Natural Products 
A variety of materials derived from natural products have been investigated as cell 
seeding scaffold materials.  Cross-links between polymer chains and various chemical bonds 
are often used to confer structural integrity to these products.  Such materials are produced 
under relatively mild conditions, possess structural and mechanical properties reminiscent of 
the extracellular matrix which can act as space fillers, bioactive molecule delivery devices or 
cell scaffolds.  Examples of such materials are given in Table 1 and include both synthetic and 
naturally derived polymers.  Of these the naturally derived polymers such as alginate, 
collagen chitosan and hyaluronate have been extensively studied as cell delivery vehicles.  
These materials provide an excellent means to transplant cells and form three-dimensional 
cell-filled matrices.  Nonetheless, such materials have several problems including variability 
in composition, poor mechanical properties and degradation rates which are time-limited and 
difficult to control. 
Hyaluronate has considerable potential as an optimal biomaterial for tissue 
engineering given the significant role it plays during organogenesis, cell migration and 
development in general (67).  Modifications to hyaluronan include esterification and cross-
linking to provide some structure and rigidity to the gel for cell seeding purposes.  These 
biopolymers are immunologically inert and completely biodegradable (14, 6) and support the 
growth of fibroblasts, chondrocytes and mesenchymal stem cells (57, 84, 12) 
Chitosan, a biopolymer that is structurally very similar to naturally occurring 
glycosaminoglycans and is biodegradable in mammals, has been used quite extensively as a 
tissue engineering scaffold.  While chitosan can support cell attachment for cell delivery 
purposes (18, 3), it is not strongly supportive of cell growth (50).  Accordingly chitosan needs 
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to be either modified chemically or conjugated with other molecules or peptides to enhance its 
biocompatibility for cell attachment (40, 45)  
Collagen scaffolds have been investigated as a means of cell delivery device for many 
years (39).  Collagen is regarded as one of the most useful biomaterials due to its excellent 
biocompatibility and safety due associated with its biological characteristics, such as 
biodegradability and weak antigenicity (Figure 4).  In this regard, collagen has been used for 
tissue engineering including skin replacement, bone substitutes, artificial blood vessels and 
valves.  In the context of this review collagen sponges and membranes offer particular 
features for cell integration and tissue engineering (Figure 5).  Cells can readily be seeded into 
collagen sponges or membranes, cultured and then introduced into a tissue defect site where 
they can effect tissue repair and regeneration (81). 
 
Synthetic Hydrogels 
Synthetic hydrogels such as poly(ethylene glycol) (PEG) and poly(ethylene oxide) (PEO) are 
also showing considerable promise for use as a three-dimensional scaffold for cell delivery.  
By varying the initial cross linking density the degradation profiles of the gel can be 
controlled (13).  In addition it is possible to construct thermally reversible hydrogels as well 
as gels which can be degraded by either hydrolytic or enzymatic means (2, 47).  PEO is 
currently FDA approved for several applications in medicine and together with PGA is one of 
the most commonly utilized synthetic materials used for tissue engineering (17). 
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Extracellular Matrix Scaffolds 
Extracellular matrix extracts or derivatives have been developed as commercial 
products for cell delivery.  In particular many skin and extracellular matrix substitutes such as 
Matrigel™ (BD Biosciences, USA) Dermagraft™ (Advanced Tissue Sciences Inc, La Jolla, 
CA, USA), Apligraf™ (Organogenesis Inc, Canton, Massachusetts) and Epidex™ (Modex 
Therapeutiques SA, Lausanne, Switzerland) have been developed to allow the incorporation 
of ex vivo expanded cells.  Nonetheless, these products, as well as other acellular therapies 
such as PV702 (GroPep Pty, Ltd, Adelaide, South Australia) and Allograft™ (Life Cell Corp, 
Branchburg, New Jersey, USA), incorporate animal derived products and/or allogenic tissues 
and thus constitute a potential source of pathogens; consequently they are unlikely to be 
routinely used a cell delivery devices in the longer term. 
In vitro produced extracellular matrix also offers potential as a biodegradable scaffold 
for cell delivery.  The use of extracellular matrix materials as scaffolds for the repair and 
regeneration of tissues is receiving increased attention. In a recent study we have shown that 
extracellular matrix formed by osteoblasts in vitro can be used as a scaffold for osteoblast 
transplantation and induce new bone formation in a critical size osseous defects in vivo (82). 
Human osteoblasts were cultured for 3 weeks to produce their own structured extracellular 
matrix (Figure 6).  The cells and self-produced matrix was then implanted into critical size 
osseous defects.  The cells inside the matrix could survive and proliferate at the recipient sites.  
It was found that bone-forming cells differentiated from both transplanted human osteoblasts 
and activated endogenous mesenchymal cells.  
 
New Directions 
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The field of tissue engineering constructs and scaffolds is expanding at a very rapid 
rate.  It would, within the confines of this review, be impossible to detail all of the most recent 
developments.  However, there are two particular new directions that the authors are 
specifically interested in which involve the co-culture of cells and nanotechnology. 
In attempts to deliver cells to a complex environment such as the periodontium it is 
possible that delivery of cells of multiple phenotypes may be required.  For example, if one 
were to want to regenerate both periodontal ligament and alveolar bone, the possibility exists 
to bilaterally seed PDL cells on one side of a bioscaffold and osteoblasts on the opposite side.  
While preliminary studies have begun to address such an approach little definitive data are yet 
available.  In a similar vein, it is not that difficult to envisage the engineering of a PDL-like 
matrix from PDL fibroblasts to which one side would then be seeded with cementoblasts and 
the opposite side seeded with osteoblasts.  Using such an approach it may be possible to fully 
reconstitute various compartments of the periodontium in vitro and then implant such 
constructs into periodontal defects. 
Advances in nanotechnology will also undoubtedly allow the synthesis of materials 
with desirable nanoscale structures.  Nanotechnology is the science of engineering at the 
individual molecular level to produce materials of hitherto unthought of properties.  Already, 
self -assembly systems have been described and fabricated which mimic many features of the 
extracellular matrix. For example, nanostructured fibrous scaffold reminiscent of extracellular 
matrix can be constructed using the pH-induced self-assembly of a peptide-amphiphile. After 
cross-linking, the fibres are able to direct mineralization of hydroxyapatite to form a 
composite material in which the crystallographic c-axes of hydroxyapatite crystals are aligned 
with the long axes of the collagen fibrils. This alignment is the same as that observed between 
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collagen fibrils and hydroxyapatite crystals in bone  (25).  Similarly, self-assembling 
biomaterials with molecular features designed to interact with cells and scaffolds for tissue 
regeneration have been reported  (31).  These nanofibres display attachment domains in the 
form of RGD motifs that are incorporated into the amphiphiles that self-assemble into 
nanofibres.  The density of the RGD motif, and perhaps soon, alternative cell signalling 
motifs, can be incorporated into the amphiphile for creation of a nanofibre with unique 
surface properties. Cells can be embedded in the nanofibre to resemble a “native” 
extracellular matrix (26).  Since these materials are chemically synthesized, they present no 
risk from viral contaminants as might occur for natural compounds recovered from biological 
sources, such as pigs or human. 
 
Concluding Comments  
The study of scaffold materials for use in tissue engineering should lead to improved 
predictability of this new technology based on cell and molecular biology.  In the future it will 
become increasingly important to consider the concepts of scaffolds which are not only space 
making and exclusionary, but also biocompatible and able to elicit appropriate gene 
expression by the cells for which it is providing the carrier capacity.  Understanding the 
complex design features necessary for successful tissue engineering, will help this technique 
to become an accepted biomedical procedure. 
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TABLE 1 
Examples of Cell Delivery Devices and Scaffolds 
Non Resorbable 
 EPTFE 
 Ceramic 
 Titanium mesh 
 
Resorbable 
 alpha-hydroxyacids 
  polyglycolic acid (PGA),  
  poly (L-lactic acid) PLLA 
  copolymers of poly(lactic-co-glycolic acid) PLGA). 
 
 Amino Acid Based Polymers 
  Collagen-like proteins 
  Elastin-like proteins 
 
 Natural Products 
  Collagen 
  Hyaluronan 
  Chitosan 
  Gelatin 
  Fibrin 
  Alginate 
 
 Synthetic Hydrogels 
  Poly(ethylene glycol) 
  Poly(ethylene oxide) 
   
 Matrix Extracts 
  Matrigel 
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Figure 2.    Cell attachment to GTR Membranes as cell delivery devices 
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Figure 3:  Culture of human PDL cells in Alginate beads. 
 
A.   Cells cultured in Alginate beads for 2 days – 10X 
B..  Cells cultured in alginate beads for 2 days – 40X 
C.   Cells cultured in alginate beads for 8 days – 20X 
D.   Cells cultured in alginate beads for 8 days – 40X 
A B 
C D 
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Figure 4:  Culture of human periodontal ligament fibroblasts and osteoblasts as single 
or mixed co-cultures in a collagen sponge.   
 
A.  Control – no cells 
B.   PDL Fibroblasts 
C.  Osteoblasts 
D.  Co-culture of osteoblasts and PDL fibroblasts 
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Figure 5   Confocal microscopy of cell penetration into collagen scaffold 
Panel A:   Cells on the surface of collagen sponges,  
Panel B:   Cells in collagen sponges at 60 µm from surface;  
Panel C:   Cells in collagen sponges at 20 µm from surface;  
Panel D:   Cells in collagen sponges at 100 µm from surface. 
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Figure 6a:  Long Term culture of human osteoblasts to produce in vitro cell / matrix 
complex.  A Low Power.  B.  High Power.  Reproduced with permission from Xiao, 
Y, Haase HR, Young WG & Bartold PM.  Development and transplantation of a 
mineralized matrix formed by osteoblasts in vitro for bone regeneration.  Cell 
Transplantation 2004; 13: 15-25. 
  
36
36
 
 
 
A        B 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6b:  Type 1 collagen distribution in long-term in vitro produced cell/matrix . A 
Low Power.  B High Power. Reproduced with permission from Xiao, Y, Haase HR, 
Young WG & Bartold PM.  Development and transplantation of a mineralized matrix 
formed by osteoblasts in vitro for bone regeneration.  Cell Transplantation 2004; 13: 
15-25. 
… 
  
37
37
 
 
 
A      B 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6c:  Von Kossa staining for calcium deposition in long-term in vitro produced 
cell/matrix   A Low Power.  B High Power. Reproduced with permission from Xiao, 
Y, Haase HR, Young WG & Bartold PM.  Development and transplantation of a 
mineralized matrix formed by osteoblasts in vitro for bone regeneration.  Cell 
Transplantation 2004; 13: 15-25. 
 
 
 
 
